EFICÁCIA DE 1200/100 MG DE DARUNAVIR/RITONAVIR ADMINISTRADO UMA VEZ POR DIA EM DOENTES INFECTADOS PELO VÍRUS DA IMUNODEFICIÊNCIA HUMANA EM UM CENTRO DE REFERÊNCIA DE PRESIDENTE PRUDENTE‐SP

EFICÁCIA DE 1200/100 MG DE DARUNAVIR/RITONAVIR ADMINISTRADO UMA VEZ POR DIA EM DOENTES INFECTADOS PELO VÍRUS DA IMUNODEFICIÊNCIA HUMANA EM UM CENTRO DE REFERÊNCIA DE PRESIDENTE PRUDENTE‐SP

Bibliographic Details
Main Authors:	Luiz Euribel Prestes Carneiro, Rodrigo Sala Ferro, Alexandre Martins Portelinha Filh, Gabriela Fernandes de Almeida Rodr, Gabriela Lie Babata, Larissa Rosa Fernandes, Vitória Taynara Peverari
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867020304190

Similar Items

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
by: Ruxandra-Cristina Marin, et al.
Published: (2021-03-01)

Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients
by: Ruxandra-Cristina Marin, et al.
Published: (2021-08-01)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
by: Tony Antoniou, et al.
Published: (2017-04-01)

A Case of Possible Darunavir/Ritonavir-Induced Peripheral Neuropathy
by: Margalit Lorber MD
Published: (2013-05-01)

Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients.
by: Takeshi Nishijima, et al.
Published: (2013-01-01)

Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study
by: Ruxandra-Cristina Marin, et al.
Published: (2023-05-01)

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.
by: Nicola Gianotti, et al.
Published: (2017-01-01)

A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients
by: Massimiliano Lanzafame, MD, et al.
Published: (2011-09-01)

DOLUTEGRAVIR + LAMIVUDINA VERSUS DARUNAVIR/RITONAVIR + LAMIVUDINA COMO ESQUEMA DE TROCA SIMPLIFICADA EM PVHA VIROLOGICAMENTE SUPRESSAS
by: Juliana Olsen Rodrigues, et al.
Published: (2022-09-01)

Short-term cost analysis of raltegravir versus atazanavir + ritonavir or darunavir + ritonavir for treatment-naive adults with HIV-1 infection in the United States.
by: Anita J Brogan, et al.
Published: (2018-01-01)

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
by: Claudio Ucciferri, et al.
Published: (2016-07-01)

Sobre el concepto de administrado
by: Antonio De Juan Abad
Published: (1962-05-01)

Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study.
by: Eman Zeyad I Elmekaty, et al.
Published: (2022-01-01)

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
by: Amedeo F. Capetti, et al.
Published: (2017-09-01)

Effect of Monotherapy with Darunavir/Ritonavir on Viral Load in Seminal Fluid, and Quality Parameters of Semen in HIV-1-Positive Patients.
by: Miguel A Lopez-Ruz, et al.
Published: (2016-01-01)

Clinical, demographic, and epidemiologic characteristics of hepatitis B virus-infected patients at a tertiary public hospital in Presidente Prudente, State of São Paulo, Brazil
by: Luiz Euribel Prestes-Carneiro, et al.
Published: (2016-02-01)

LAS GARANTIAS DE LOS DERECHOS DE LOS ADMINISTRADOS.
by: José Gascón y Marín
Published: (1951-02-01)

Eficacia y seguridad del aborto medicamentoso auto-administrado versus administrado por profesionales de la salud
by: Eros Miguel Angeletti
Published: (2021-05-01)

Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.
by: Elżbieta Jabłonowska, et al.
Published: (2019-01-01)

Characteristics and early outcomes of children and adolescents treated with darunavir/ritonavir raltegravir or etravirinecontaining antiretroviral therapy in the Western Cape Province of South Africa
by: J Nuttall, et al.
Published: (2018-02-01)

High drug loading solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsions for the dual drug delivery of the HIV drugs darunavir and ritonavir
by: Heba Elkateb, et al.
Published: (2023-10-01)

Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
by: Antinori A, et al.
Published: (2016-05-01)

Recepción de los administrados en los organismos públicos
by: Rafael Ansón Oliart
Published: (1967-05-01)

Las relaciones de la Administración con los administrados
by: M. Marceau Long
Published: (1965-05-01)

Virologic and Immunologic Effectiveness at 48 Weeks of Darunavir–Ritonavir-Based Regimens in Treatment-Experienced Persons Living with HIV-1 Infection in Clinical Practice
by: Fernando Martín Biscione MD, PhD, et al.
Published: (2014-01-01)

The Effect of Solvents and Drying Temperature on the Physicochemical Properties of Darunavir and Darunavir Ethanolate Substances
by: S. A. Zolotov, et al.
Published: (2021-02-01)

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
by: Charlotte Charpentier, et al.
Published: (2013-01-01)

Sarcoma de Kaposi variante queloidiana associada à síndrome da imunodeficiência adquirida (SIDA)
by: Mariana Morais Tavares Colferai, et al.
Published: (2017-10-01)

Servicio de dispensación: interacción entre darunavir y quetiapina
by: Damià Barris Blundell, et al.
Published: (2022-10-01)

Micobactérias atípicas em doentes sem síndroma de imunodeficiência adquirida
by: A. Marinho, et al.
Published: (2008-05-01)

SÍNDROME DA IMUNODEFICIÊNCIA ADQUIRIDA EM IDOSOS BRASILEIROS
by: LAÍS GUARNIERI CAMPIOTTO, et al.
Published: (2013-10-01)

INFILTRAÇÃO INTRALESIONAL DE GLUCANTIME EM LEISHMANIOSE TEGUMENTAR: UM RELATO DE CASO
by: Daniel Bazan Corral, et al.
Published: (2021-01-01)

Mimese e verdade no mundo administrado
by: Pedro Hussak
Published: (2018-10-01)

RELATO PRÁTICO DE OFICINA DE JORNALISMO IMPRESSO NO ENSINO FUNDAMENTAL DE PRESIDENTE PRUDENTE (SP)
by: Gabriel Batista Mota, et al.
Published: (2019-07-01)

RELATO PRÁTICO DE OFICINA DE JORNALISMO IMPRESSO NO ENSINO FUNDAMENTAL DE PRESIDENTE PRUDENTE (SP)
by: Gabriel Batista Mota, et al.
Published: (2019-07-01)

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.
by: Sidonie Lambert-Niclot, et al.
Published: (2012-01-01)

Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial
by: Eduardo Arathoon, et al.
Published: (2017-01-01)

Plataformas digitais e uberização: a globalização de um Sul administrado?
by: Ludmila Costhek Abílio
Published: (2020-04-01)

Suscetibilidade de camondongos ao virus amarílico administrado por vias extraneurais
by: Herminio Linhares
Published: (1943-01-01)

La colaboración social de los administrados en la gestión tributaria
by: Juan Ortiz De Mendívil
Published: (1969-05-01)